SaharZFaghihDO(She/Her)

Allergy & Immunology • Newport Beach, CA

Board Certified Physician, Speaker, Key Opinion Leader, Principle investigator, Healthcare Consultant, Influencer

Join to view full profile

Dr. Faghih is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Faghih's full profile

Already have an account?

Office
4000 MacArthur Blvd
#600
Newport Beach, CA 92660
Phone+1 714-919-9057

Education & Training

Detroit Medical Center CorporationFellowship, Allergy and Immunology, 2010 - 2012
University of South Florida MorsaniResidency, Pediatrics, 2007 - 2010
Nova Southeastern University College of Osteopathic MedicineClass of 2007

Certifications & Licensure

CA State License 2014 - 2025
MA State License 2012 - 2013
MI State License 2010 - 2013
FL State License 2010 - 2012
American Board of Allergy and Immunology Allergy & Immunology
American Board of Pediatrics Pediatrics

Clinical Trials

Study Assessing Long-teRm Outcomes of dupiluMAb (DUPIXENT®) Treatment in Adult Patients With Chronic Rhinosinusitis With Nasal Polyposis (CRSwNP) Start of enrollment: 2021 Aug 12
Active, not recruiting
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (LOGOS) Start of enrollment: 2021 Mar 01
Recruiting
Phase 3
Effectiveness and Safety Study of Tezepelumab in Adults & Adolescent Participants With Severe Asthma in the United States Start of enrollment: 2022 Apr 29
Recruiting
Phase 4
Study to Compare Efficacy Safety and Immunogenicity of ADL-018 With XOLAIR (Omalizumab) in Adults With Chronic Idiopathic Urticaria Start of enrollment: 2023 Aug 15
Recruiting
Phase 3
The Purpose of This Study is to Evaluate the Effects of Ruxolitinib Cream on Adults With Atopic Dermatitis Experiencing Sleep Disturbance. Start of enrollment: 2023 Mar 16
Recruiting
Phase 4
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol Sulfate is Effective in Preventing Asthma Exacerbations Start of enrollment: 2023 Aug 30
Recruiting
Phase 3
Efficacy of Dupilumab Added to Medium Dose Inhaled Corticosteroid/Long-acting Beta-agonist (ICS/LABA) in Comparison to ICS Dose Escalation to High Dose ICS/LABA in Adolescent and Adult Patients With Uncontrolled Asthma
Join now to see all

Publications & Presentations

PubMed

3 citations
Increased Adolescent HIV Infection during Pregnancy Leads to Increase in Perinatal Transmission at Urban Referral Center
Sahar Faghih, Elizabeth Secord
Journal of the International Association of Physicians in AIDS Care. 2012-05-24

Industry Relationships

SPEAKER, Astra Zeneca2024 - Present